Susquehanna Fundamental Investments’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
RSCM
N
GPP
Susquehanna Fundamental Investments's RIGL Position: Q1 2022 in Review
Susquehanna Fundamental Investments reduced its Rigel Pharmaceuticals (RIGL) stake by 63% in Q1 2022, selling an estimated $204K and leaving 4,435 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.
Susquehanna Fundamental Investments first reported a position in RIGL in Q2 2021 and has held it in 4 quarters since. The position peaked at $317K in Q4 2021. 163 funds tracked by Wall St. Rank hold RIGL as of Q1 2022.
- Susquehanna Fundamental Investments held 4,435 shares of Rigel Pharmaceuticals worth $133K as of Q1 2022.
- Susquehanna Fundamental Investments sold 7,530 Rigel Pharmaceuticals shares in Q1 2022, an estimated $204K.
- Rigel Pharmaceuticals made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1425 holding.
- Susquehanna Fundamental Investments first reported a position in Rigel Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
- Susquehanna Fundamental Investments's Rigel Pharmaceuticals position peaked at $317K in Q4 2021.
- 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2022.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.